• Immunitybio Inc is trading 4.9% higher at $7.05 as it garners retail attention ahead of the Russell index reconstitution later this month.
  • Investors are anticipating passive fund inflows as the company potentially graduates into the Russell 1000 Index.
  • This comes after a 5.8% decline in the previous session.